Cabot Corporation
CBT
$84.88
$0.810.96%
| Weiss Ratings | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B+ | |||
| Rating Factors | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.41 | |||
| Price History | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.53% | |||
| 30-Day Total Return | -4.59% | |||
| 60-Day Total Return | -18.78% | |||
| 90-Day Total Return | -22.42% | |||
| Year to Date Total Return | -4.02% | |||
| 1-Year Total Return | -1.78% | |||
| 2-Year Total Return | 11.32% | |||
| 3-Year Total Return | 32.42% | |||
| 5-Year Total Return | 193.84% | |||
| 52-Week High % Change | -28.43% | |||
| 52-Week Low % Change | 5.66% | |||
| Price | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $117.46 | |||
| 52-Week Low Price | $79.57 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Nov 07, 2024 | |||
| Valuation | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.56B | |||
| Enterprise Value | 5.72B | |||
| Price/Earnings (TTM) | 11.17 | |||
| Earnings Per Share (TTM) | 7.53 | |||
| Earnings Per Share Growth | -2.19% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.16 | |||
| Price/Book (Q) | 3.34 | |||
| Enterprise Value/Revenue (TTM) | 1.43 | |||
| Price | $84.88 | |||
| Enterprise Value/EBITDA (TTM) | 7.23 | |||
| Enterprise Value/EBIT | 8.97 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 55.00M | |||
| Dividend Yield | 2.05% | |||
| Div. Per Share (Most Recent) | $0.43 | |||
| Dividend Per Share (TTM) | $1.72 | |||
| Payout Ratio (TTM) | 22.46% | |||
| Dividend Per Share (Most Recent) | $0.43 | |||
| Company Info | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 617 345 0100 | |||
| Address | Two Seaport Lane Boston, MA 02210-2019 | |||
| Website | www.cabotcorp.com | |||
| Country | United States | |||
| Year Founded | 1882 | |||
| Profitability | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 15.98% | |||
| Profit Margin | 10.59% | |||
| Management Effectiveness | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 10.87% | |||
| Return on Equity | 31.24% | |||
| Income Statement | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.99B | |||
| Total Revenue (TTM) | 3.99B | |||
| Revenue Per Share | $72.56 | |||
| Gross Profit (TTM) | 980.00M | |||
| EBITDA (TTM) | 791.00M | |||
| EBIT (TTM) | 638.00M | |||
| Net Income (TTM) | 423.00M | |||
| Net Income Avl. to Common (TTM) | 423.00M | |||
| Total Revenue Growth (Q YOY) | -0.31% | |||
| Earnings Growth (Q YOY) | 70.49% | |||
| EPS Diluted (TTM) | 7.53 | |||
| EPS Diluted Growth (Q YOY) | 89.77% | |||
| Balance Sheet | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 183.00M | |||
| Cash Per Share (Q) | $3.33 | |||
| Total Current Assets (Q) | 1.50B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.52B | |||
| Current Ratio (Q) | 2.003 | |||
| Book Value Per Share (Q) | $25.20 | |||
| Total Assets (Q) | 3.64B | |||
| Total Current Liabilities (Q) | 747.00M | |||
| Total Debt (Q) | 1.20B | |||
| Total Liabilities (Q) | 2.13B | |||
| Total Common Equity (Q) | 1.37B | |||
| Cash Flow | CBT - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -285.00M | |||
| Cash from Financing (TTM) | -410.00M | |||
| Net Change in Cash (TTM) | -61.00M | |||
| Levered Free Cash Flow (TTM) | 383.63M | |||
| Cash from Operations (TTM) | 711.00M | |||
